What is drug half-life?

What half-life measures

Half-life, often written t½, captures the rate at which a drug disappears from the bloodstream. If a drug’s concentration halves over a fixed period, it falls by half again over the next equal period, and so on — a pattern characteristic of first-order elimination, where a constant fraction is removed per unit time. Half-life is one of the central parameters of pharmacokinetics, sitting alongside clearance (the rate of removal) and volume of distribution (how widely the drug spreads into tissues); in fact half-life is mathematically related to those two. It is a descriptive, quantitative concept used in research, not a rule for how a medicine should be taken.

What determines a drug’s half-life

A drug’s half-life depends on how the body handles it — chiefly the ADME processes of metabolism and excretion. A drug cleared rapidly by the liver or kidneys tends to have a short half-life, while one removed slowly persists longer. Half-life is closely tied to clearance and volume of distribution: broadly, slower clearance or wider tissue distribution lengthens it. Because these factors are properties of both the drug and the biological system, half-life is a useful summary of a candidate’s behaviour that scientists characterise during drug development.

Why half-life matters in research

Half-life helps researchers reason about how a drug’s exposure changes over time. It informs how long it takes for a drug to be largely eliminated after exposure stops, and conceptually relates to how exposure builds toward a steady state during repeated administration in study design. These are matters of pharmacokinetic understanding used to design and interpret studies.

Half-life is best understood as a characteristic that describes drug behaviour, not as personal dosing guidance. The specifics of how any individual medicine should be used are clinical questions addressed in approved product information, well outside the scope of this educational concept.